Hap Trading, LLC Dynavax Technologies Corp Put Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	BUY	$9.75 - $14.44 $242,775 - $359,556	24,900 Added 163.82%	40,100 $310,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $151,455 - $240,810	-11,500 Reduced 43.07%	15,200 $21,000
Q3 2021 Nov 10, 2021	BUY	$9.16 - $19.83 $91,600 - $198,299	10,000 Added 59.88%	26,700 $22,000
Q2 2021 Aug 11, 2021	SELL	$7.25 - $10.99 $39,875 - $60,445	-5,500 Reduced 24.77%	16,700 $10,000
Q1 2021 May 14, 2021	SELL	$4.57 - $11.18 $9,140 - $22,360	-2,000 Reduced 8.26%	22,200 $25,000
Q4 2020 Feb 16, 2021	BUY	$3.73 - $5.6 $40,284 - $60,479	10,800 Added 80.6%	24,200 $65,000
Q3 2020 Nov 13, 2020	BUY	$4.32 - $11.7 $3,024 - $8,189	700 Added 5.51%	13,400 $46,000
Q1 2020 May 08, 2020	SELL	$2.27 - $6.2 $109,641 - $299,460	-48,300 Reduced 79.18%	12,700 $24,000
Q1 2019 May 10, 2019	SELL	$7.08 - $12.09 $418,428 - $714,519	-59,100 Reduced 49.21%	61,000 $113,000
Q4 2018 Feb 12, 2019	BUY	$8.14 - $13.28 $977,614 - $1.59 Million	120,100 New	120,100 $185,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.